Clinical Study
Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
Table 4
Rate of antimicrobial resistance of Helicobacter pylori.
| | Antimicrobial resistance, n (%) | RAK () | BRAK () | value | Total () |
| | Etronidazole | 11 (28.9) | 11 (25.6) | 0.73 | 22 (27.2) | | Clarithromycin | 5 (13.2) | 5 (11.6) | 0.83 | 10 (12.3) | | Tetracycline | 0 (0.0) | 0 (0.0) | — | 0 (0.0) | | Levofloxacin | 3 (7.9) | 6 (14.0) | 0.38 | 9 (11.1) | | Amoxicillin | 1 (2.6) | 1 (2.3) | 0.93 | 2 (2.5) |
|
|
